Your cart is empty
Fewer Australians are dying from hepatitis C
The number of Australians dying from liver failure and liver cancer related to hepatitis C has dropped by 20 per cent in just two years, according to preliminary data released today by The Kirby Institute. It follows the introduction of highly effective, low-cost curative drugs to the Pharmaceutical Benefits Scheme (PBS) in 2016.
“This decline reflects the high uptake of direct-acting antiviral therapies among people with hepatitis C, particularly those with more advanced liver disease,” said Greg Dore from the Kirby Institute.
www.abc.net.au/news/health/2018-08-13/fewer-australians-dying-from-hepatitis-c
